Found: 15
Select item for more details and to access through your institution.
Overexpression of ABCB1 Associated With the Resistance to the KRAS-G12C Specific Inhibitor ARS-1620 in Cancer Cells.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.843829
- By:
- Publication type:
- Article
Overexpression of ABCB1 Transporter Confers Resistance to mTOR Inhibitor WYE-354 in Cancer Cells.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 4, p. 1387, doi. 10.3390/ijms21041387
- By:
- Publication type:
- Article
Chk1 Inhibitor MK-8776 Restores the Sensitivity of Chemotherapeutics in P-glycoprotein Overexpressing Cancer Cells.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 17, p. 4095, doi. 10.3390/ijms20174095
- By:
- Publication type:
- Article
Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer.
- Published in:
- Molecular Cancer, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12943-022-01587-9
- By:
- Publication type:
- Article
Design, Synthesis and Biological Evaluation of Quinazolinamine Derivatives as Breast Cancer Resistance Protein and P-Glycoprotein Inhibitors with Improved Metabolic Stability.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 2, p. 253, doi. 10.3390/biom13020253
- By:
- Publication type:
- Article
VKNG-1 Antagonizes ABCG2-Mediated Multidrug Resistance via p-AKT and Bcl-2 Pathway in Colon Cancer: In Vitro and In Vivo Study.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4675, doi. 10.3390/cancers13184675
- By:
- Publication type:
- Article
VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters.
- Published in:
- Frontiers in Pharmacology, 2018, p. 1, doi. 10.3389/fphar.2018.01236
- By:
- Publication type:
- Article
Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells.
- Published in:
- Frontiers in Pharmacology, 2018, p. N.PAG, doi. 10.3389/fphar.2018.01097
- By:
- Publication type:
- Article
Midostaurin Reverses ABCB1-Mediated Multidrug Resistance, an in vitro Study.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00514
- By:
- Publication type:
- Article
Glesatinib, a c-MET/SMO Dual Inhibitor, Antagonizes P-glycoprotein Mediated Multidrug Resistance in Cancer Cells.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00313
- By:
- Publication type:
- Article
Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression.
- Published in:
- Molecules, 2019, v. 24, n. 23, p. 4383, doi. 10.3390/molecules24234383
- By:
- Publication type:
- Article
Modulating the function of ABCB1: in vitro and in vivo characterization of sitravatinib, a tyrosine kinase inhibitor.
- Published in:
- Cancer Communications, 2020, v. 40, n. 7, p. 285, doi. 10.1002/cac2.12040
- By:
- Publication type:
- Article
Cycloruthenated Self‐Assembly with Metabolic Inhibition to Efficiently Overcome Multidrug Resistance in Cancers.
- Published in:
- Advanced Materials, 2022, v. 34, n. 1, p. 1, doi. 10.1002/adma.202100245
- By:
- Publication type:
- Article
Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells in vitro.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. 1, doi. 10.3389/fonc.2020.00700
- By:
- Publication type:
- Article
Reversal Effect of ALK Inhibitor NVP-TAE684 on ABCG2-Overexpressing Cancer Cells.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. 1, doi. 10.3389/fonc.2020.00228
- By:
- Publication type:
- Article